Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

$10 Million Bet On NortonLifeLock? 4 Stocks Insiders Are Buying

Published 21/09/2022, 14:31
Updated 21/09/2022, 15:10
© Reuters.  $10 Million Bet On NortonLifeLock? 4 Stocks Insiders Are Buying

© Reuters. $10 Million Bet On NortonLifeLock? 4 Stocks Insiders Are Buying

Although US stocks closed lower on Tuesday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

NortonLifeLock

  • The Trade: NortonLifeLock Inc. (NASDAQ: NLOK) President Ondrej Vleck acquired a total of 456,475 shares an average price of $21.91. To acquire these shares, it cost around $10 million.
  • What’s Happening: NortonLifeLock, last month, reported worse-than-expected Q1 sales results.
  • What NortonLifeLock Does: NortonLifeLock is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers.
CNA Financial
  • The Trade: CNA Financial Corporation (NYSE: CNA) 10% owner Loews Corp (NYSE:L) acquired a total of 204,697 shares at an average price of $38.88. To acquire these shares, it cost around $7.96 million.
  • What’s Happening: CNA Financial, last month, reported worse-than-expected Q2 EPS results..
  • What CNA Financial Does: CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance.
Don’t forget to check out our premarket coverage here .

Also check this: Fear Among US Investors Is Increasing, Here's Why

Braze

  • The Trade: Braze, Inc. (NASDAQ: BRZE) Director Matthew Jacobson bought a total of 414,137 shares at an average price of $35.01. To acquire these shares, it cost around $14.5 million.
  • What’s Happening: Braze recently reported Q2 earnings results and issued Q3 adjusted EPS guidance below estimates.
  • What Braze Does: Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands.
Medpace Holdings
  • The Trade: Medpace Holdings, Inc. (NASDAQ: MEDP) 10% owner Medpace Investors LLC bought a total 156,635 shares at an average price of $151.92. The insider spent around $23.8 million to buy those shares.
  • What’s Happening: UBS recently initiated coverage on Medpace Hldgs with a Sell rating and announced a price target of $142.
  • What Medpace Does: Medpace Holdings Inc is a clinical contract research organization.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.